This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Uncategorised Disease
  • /
  • Management of poor-risk metastatic renal cell carc...

Management of poor-risk metastatic renal cell carcinoma: current approaches, the role of temsirolimus and future directions.

Read time: 1 mins
Published:25th Mar 2020
Author: Porta C, Tortora G, Larkin JM, Hutson TE.
Source: Future Oncology
Ref.:Future Oncol. 2016 Feb;12(4):533-49.
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest